Trial Profile

A Phase 2a Study to Evaluate the Clinical Effect, Pharmacokinetics, Safety and Tolerability of Topically Applied Umeclidinium in Subjects With Primary Palmar Hyperhidrosis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 26 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Umeclidinium (Primary)
Indications Hyperhidrosis
Focus Proof of concept; Therapeutic Use
Sponsors Stiefel Laboratories

Most Recent Events

20 Dec 2016 Status changed from active, no longer recruiting to completed.
28 Nov 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016.
28 Nov 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2016.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com